Steroid, Thiamine and Ascorbic Acid for Comatose Out-of-hospital Cardiac Arrest Survivors
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 160 participants.
Also called NCT04921189
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 160 participants
- Sponsor
- Registry
-
NCT04921189
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT04921189. Randomized; double masking; primary purpose treatment. Start 2021-12-31 (actual); primary completion 2024-12-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Steroid, Thiamine and Ascorbic Acid for Comatose Out-of-hospital Cardiac Arrest Survivors
- Condition
- Out-Of-Hospital Cardiac Arrest
- Condition
- Postcardiac Arrest Syndrome
- Intervention (Drug)
- The combined supplement of Ascorbic acid, Thiamine, and Cortisol
- Intervention (Drug)
- Placebo
- Lead sponsor
- Asan Medical Center
- Collaborator
- Seoul St. Mary's Hospital
- Collaborator
- Wonju Severance Christian Hospital
- Collaborator
- Samsung Changwon Hospital
- Collaborator
- Samsung Medical Center
- Collaborator
- Chung-Ang University
- Collaborator
- Hanyang University
- Collaborator
- Ewha Womans University
- Collaborator
- Hanil General Hospital
Record details
- Record id
cardio:ct-nct04921189- Content hash
3267b75b34a87723106c7d5db52e6796166e61e150991ab78efe16737c56d8f8